MAPT and Alzheimer disease: In addition, we analyzed the correlation between A.H.T. use and the available brain neuropathology assessed by immunohistochemistry and neuroimaging data, as well as the cerebrospinal fluid (CSF) biomarkers such as A-β42, T-tau and p-181tau, to gain further insights in participants who were diagnosed with AD upon post-mortem autopsy.